Lipoprotein-associated phospholipase A2 (Lp-PLA2) was recently characterized as a novel inflammatory biomarker correlated with several components constituting the MetS and implicated in atherosclerosis, incident cardiovascular disease [8,9]. Here, PLA2G7 is linked to metabolic syndrome.